Provided by Tiger Trade Technology Pte. Ltd.

WUXI BIO

55.150
-1.550-2.73%
Volume:17.37M
Turnover:978.18M
Market Cap:227.00B
PE:40.58
High:57.250
Open:56.700
Low:55.000
Close:56.700
52wk High:58.000
52wk Low:28.480
Shares:4.12B
HK Float Shares:4.12B
Volume Ratio:1.90
T/O Rate:0.42%
Dividend:- -
Dividend Rate:- -
EPS(LYR):1.359
ROE:11.38%
ROA:7.60%
PB:4.03
PE(LYR):40.58
PS:8.21

Loading ...

Wuxi Biologics (Cayman) Stock Slips 2.7% in Hong Kong

Dow Jones
·
Sep 10

Movement Alert|WUXI BIO Falls 3.07% in Regular Trading, Trading at 47.44 HKD

Market Focus
·
Sep 10

WuXi Biologics Issues 1.20 Million New Shares; 39.82 Million Shares Await Cancellation

Bulletin Express
·
Sep 09

WuXi Biologics Files HKEX Next-Day Disclosure, Share Capital Rises by 1.2 Million Shares

Reuters
·
Sep 09

Transcenta Licenses HiCB Bioprocessing Technology to WuXi Biologics for RMB 10 Million Upfront

Reuters
·
Sep 09

Transcenta Holding - to Receive RMB 10 Mln Upfront Payment and Milestone Payments

THOMSON REUTERS
·
Sep 09

Transcenta Holding - Grants WuXi Biologics Non-Exclusive License to Hicb Platform and Excelpro Cell Culture Media

THOMSON REUTERS
·
Sep 09

Wuxi Biologics (Cayman) Stock Climbs 1.7% in Hong Kong

Dow Jones
·
Sep 08

WuXi Biologics Files HKEX Next-Day Disclosure Return, Issues 1,804,090 New Shares

Reuters
·
Sep 07

Wuxi Biologics (Cayman) Stock Slides 1.4% in Hong Kong

Dow Jones
·
Sep 07

WuXi Bio Issues 3.2 Million Shares Following Option Exercise

Stock News
·
Sep 04

Wall Street Cues, Easing Bond Yields Boost Asian Stock Markets

MT Newswires Live
·
Sep 04

Movement Alert|WUXI BIO Falls 3.12% in Regular Trading, Post-Earnings Profit-Taking and CXO Sector Pullback Weigh on Shares

Market Focus
·
Sep 04

WuXi Biologics Files HKEX Next-Day Disclosure Return, Share Capital Rises by 2,423,900 Shares

Reuters
·
Sep 03

Wuxi Biologics (Cayman) Stock Advances 3.0% in Hong Kong

Dow Jones
·
Sep 03

Movement Alert|WUXI BIO Rises 3.27% in Regular Trading, Large-Scale Buyback of Over HK$1.27 Billion Boosts Market Confidence

Market Focus
·
Sep 03

WuXi Biologics Files HKEX Next-Day Disclosure Return Reporting 1,527,500 New Shares Issued Via Option Exercises

Reuters
·
Sep 02

Wuxi Biologics (Cayman) Stock Slips 3.6% in Hong Kong

Dow Jones
·
Aug 31

WuXi Biologics' Stronger Project Backlog Could Underpin Revenue Visibility

Dow Jones
·
Aug 31

Movement Alert|WUXI BIO Falls 4.4% in Regular Trading, Profit-Taking Extends After Strong Interim Results

Market Focus
·
Aug 31